发现强大和选择性的林基通道类受体9对手
Xue Song1, Chen-Guo Feng1, Chen Wang2
1Research Center of Chiral Drug, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P. R. China.
研究人员发现了强大的托尔类受体9 (TLR9) 抗剂,如化合物38,为TLR9相关疾病提供了有前途的治疗方法. 这些选择性抑制剂显示出作为药理学工具和候选药物的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 收费类受体 (TLRs) 是关键的先天性免疫传感器,可以识别微生物模式.
- 收费类受体9 (TLR9) 在细菌和病毒DNA中检测CpG基因,这对免疫反应至关重要.
- 由于TLR9的复杂作用,开发针对TLR9的治疗方法具有挑战性.
研究的目的:
- 发现和描述Toll类受体9 (TLR9) 的新型,强效和选择性抑制剂.
- 评估这些抑制剂作为TLR9介导疾病的药理学工具和治疗剂的潜力.
主要方法:
- 一系列新型TLR9抗剂的药用化学合成.
- 在体外生化测试以确定抑制功效 (IC50) 和针对各种TLR的选择性.
- 对化合物的药理动力学和药理动力学评估.
主要成果:
- 发现化合物5- ((hexahydropyrrolo-[3,4-b]-pyrrol-1-(2H) -yl) -quinoline (38) 作为一种强大的TLR9对手.
- 化合物38对人类TLR9的IC50为0.1nM,对其他TLR的选择性>10,000倍 (TLR2/4/5/7/8).
- 化合物38显示出有利的药理动力学和药理动力学特征.
结论:
- 化合物38在开发TLR9向疗法的过程中取得了重大进展.
- 已确定的TLR9抗剂对治疗TLR9相关的炎症和自身免疫性疾病具有前景.
- 这些化合物可以作为宝贵的药理学工具,用于进一步研究TLR9功能.
更多相关视频
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
相关概念视频
Gene Regulation in Microbial Communities: Quorum Sensing
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug Discovery: Overview
